New research provides the most up-to-date glyphosate and its relationship with the Non-Hodgkin’s lymphoma, a type of cancer to the lymph nodes, incorporating more than 54-thousand people who work as pesticide applicators with license.
According to the study, herbicides with glyphosate, the main component of Monsanto’s commercial formula, increase the risk of developing a type of cancer by 41%.
In this regard, the medical director of the Cancer Detector Center and oncologist surgeon, Mauricio León Rivera, mentioned that glyphosate is a chemical compound that is used for the elimination of plants that alter ecosystems and its use is very common in agriculture, and it is also found in gardening products from many countries such as Peru.
He also mentioned that the World Health Organization (WHO) said that “there is convincing evidence that glyphosate can cause cancer in laboratory animals, as well as limited evidence of carcinogenicity in humans (non-Hodgkin lymphoma).” That is why they have reclassified their dangerousness by including this agent in Group 2A as “probably carcinogenic”.
The authors of the study state that this new analysis evaluates all publications on the effect of the herbicide on humans, what is called a meta-analysis focusing on those who have had higher exposures, so that the results are not altered by those who have barely been near the herbicide. If there was no relationship between glyphosate and cancer, individuals would not develop the disease more often.